Clinical Trial Update: Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating melatonin for youth with ADHD and initial insomnia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Initial Insomnia

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: University of Alberta | Conditions: Attention Deficit/Hyperactivity Disorder, Initial Insomnia | Phase 3 | Status: WITHDRAWN